Pinnacle Summer Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-12,056
Closed -$993K 933
2015
Q3
$993K Buy
+12,056
New +$1.07M 0.17% 115
2015
Q2
Sell
-13,183
Closed -$1.17M 877
2015
Q1
$1.17M Sell
13,183
-503
-4% -$44.6K 0.16% 121
2014
Q4
$1.14M Sell
13,686
-279
-2% -$23.1K 0.14% 124
2014
Q3
$1.18M Sell
13,965
-943
-6% -$76.3K 0.13% 115
2014
Q2
$1.21M Hold
14,908
0.14% 107
2014
Q1
$1.16M Buy
14,908
+676
+5% +$49.3K 0.15% 101
2013
Q4
$1.02M Buy
14,232
+1,937
+16% +$135K 0.14% 100
2013
Q3
$845K Buy
12,295
+949
+8% +$62.8K 0.15% 111
2013
Q2
$719K Buy
+11,346
New +$738K 0.18% 104

Other funds holding NVS

Pinnacle Summer Investments's NVS Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of Novartis (NVS) in Q4 2015, closing a stake of 12,056 shares — an estimated $993K sold.

Pinnacle Summer Investments first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $1.21M in Q2 2014. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • Pinnacle Summer Investments reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 12,056 Novartis shares in Q4 2015, an estimated $993K.
  • Pinnacle Summer Investments first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
  • Pinnacle Summer Investments's Novartis position peaked at $1.21M in Q2 2014.
  • 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.